Episode 66: SPONSORED | New Hope for Fibromyalgia Patients with Erik Lundquist, MD

As a clinician interested in participating in research, it’s very
exciting to see others jumping into the research conversation, too.
Today I talk to Dr. Erik Lundquist, who heads a large, integrative
clinic out in Southern California. Erik recently completed a
clinical pilot study looking at the use of SPMs (just 2 gelcaps per
day) in patients diagnosed with fibromyalgia (Dr. Lundquist reports
that the bulk of these patients have underlying mold exposure or
Lyme as the primary etiology for FMS). While labs and pain scores
didn’t improve markedly in the population, there was a clear,
statistically significant jump in quality of life for these folks.
In fact, Dr. L suspects that the increased movement and engagement
in life probably influenced the lack of drop in pain. And further,
Dr. L pointed out that standard labs such as CRP were NOT elevated
at baseline in the chronic mold/Lyme population. Listen to the
details, and Erik’s story. If you are wanting to participate in
clinical research yourself, I’d love to hear about it, and, as
always, I appreciate you listening and ask that you please rate,
comment and share New Frontiers with your colleagues! ~DrKF